Meeting
2022 ASCO Annual Meeting
Staging locally advanced cervical cancer with FIGO 2018 versus FIGO 2008: Impact on overall survival and progression-free survival in the OUTBACK trial (ANZGOG 0902, RTOG 1174, NRG 0274).
Authors
Linda R. Mileshkin
Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia
Linda R. Mileshkin , Kathleen N. Moore , Elizabeth H Barnes , Yeh Chen Lee , Val Gebski , Kailash Narayan , Nathan Bradshaw , Katrina Diamante , Anthony W. Fyles , William Small Jr., David K. Gaffney , Pearly Khaw , Susan Brooks , J Spencer Thompson , Warner King Huh , Matthew Carlson , Katina Robison , Danny Rischin , Martin R. Stockler , Bradley J. Monk
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gynecologic Cancer
Track
Gynecologic Cancer
Sub Track
Cervical Cancer
Clinical Trial Registration Number
ACTRN12610000732088
Citation
J Clin Oncol 40, 2022 (suppl 16; abstr 5531)
DOI
10.1200/JCO.2022.40.16_suppl.5531
Abstract #
5531
Poster Bd #
410
Abstract Disclosures
Similar Posters
Poster
2011 ASCO Annual Meeting
Comparison of 12 current staging systems for advanced hepatocellular carcinoma not amendable to locoregional therapy as inclusion criteria for clinical trials.
First Author: X. Li
Poster
2024 ASCO Annual Meeting
Racial disparities and survival outcome of patients with locally advanced cervix cancer in the international randomised phase 3 OUTBACK trial (ANZGOG 0902, RTOG 1174, NRG 0274).
First Author: Yeh Chen Lee
Poster
2023 ASCO Annual Meeting
The RESECT study: Factors associated with overall survival (OS) and relapse-free survival (RFS) among patients with stages I–III resected NSCLC without known EGFR mutations.
First Author: Jhanelle Elaine Gray
Poster
2023 ASCO Annual Meeting
The value of progression-free survival at three years as a primary endpoint for studies on radiotherapy in patients with locally advanced cervical cancer: Individual patient data from Chinese National Cancer Center and validation from 27 global randomized trials.
First Author: Xi Yang